These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

116 related articles for article (PubMed ID: 7092289)

  • 1. Defective yeast opsonisation and functional deficiency of complement in sickle cell disease.
    Larcher VF; Wyke RJ; Davis LR; Stroud CE; Williams R
    Arch Dis Child; 1982 May; 57(5):343-6. PubMed ID: 7092289
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Defective opsonisation and complement deficiency in serum from patients with fulminant hepatic failure.
    Wyke RJ; Rajkovic IA; Eddleston AL; Williams R
    Gut; 1980 Aug; 21(8):643-9. PubMed ID: 7000632
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Bacterial and fungal infection in children with fulminant hepatic failure: possible role of opsonisation and complement deficiency.
    Larcher VF; Wyke RJ; Mowat AP; Williams R
    Gut; 1982 Dec; 23(12):1037-43. PubMed ID: 6757064
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Yeast opsonisation and complement in children with liver disease. Analysis of 69 cases.
    Larcher VF; Wyke RJ; Vergani D; Mowat AP; Williams R
    Pediatr Res; 1983 Apr; 17(4):296-300. PubMed ID: 6343990
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Mechanism of the serum defect in yeast opsonization in children with fulminant hepatic failure (FHF).
    Larcher VF; Wyke RJ; Mowat AP; Williams R
    Clin Exp Immunol; 1981 Nov; 46(2):406-11. PubMed ID: 7039888
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Relation between serum opsonic activity for Streptococcus pneumoniae and complement function in sickle cell disease.
    Bjornson AB; Lobel JS; Harr KS
    J Infect Dis; 1985 Oct; 152(4):701-9. PubMed ID: 3930618
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Activity of the alternative complement pathway after splenectomy: comparison to activity in sickle cell disease and hypogammaglobulinemia.
    Corry JM; Polhill RB; Edmonds SR; Johnston RB
    J Pediatr; 1979 Dec; 95(6):964-9. PubMed ID: 387939
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Lack of a requirement for the Fc region of IgG in restoring pneumococcal opsonization via the alternative complement pathway in sickle cell disease.
    Bjornson AB; Lobel JS
    J Infect Dis; 1986 Nov; 154(5):760-9. PubMed ID: 3095435
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Direct evidence that decreased serum opsonization of Streptococcus pneumoniae via the alternative complement pathway in sickle cell disease is related to antibody deficiency.
    Bjornson AB; Lobel JS
    J Clin Invest; 1987 Feb; 79(2):388-98. PubMed ID: 3805275
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Opsonisation and phagocytosis of group B meningococci by polymorphonuclear leucocytes: comparison of sulphonamide sensitive and resistant strains.
    Ward KN; Fleer A; Verhoef J; Jones DM
    J Clin Pathol; 1987 Apr; 40(4):361-7. PubMed ID: 3108325
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Deficiency of factor B of the complement system in sickle cell anaemia.
    Wilson WA; Hughes GR; Lachmann PJ
    Br Med J; 1976 Feb; 1(6006):367-9. PubMed ID: 1247858
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Complement activation in asymptomatic patients with sickle cell anaemia.
    Wilson WA; Thomas EJ; Sissons JG
    Clin Exp Immunol; 1979 Apr; 36(1):130-9. PubMed ID: 466858
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Infection and immunity in sickle cell disease].
    Falcão RP; Donadi EA
    AMB Rev Assoc Med Bras; 1989; 35(2):70-4. PubMed ID: 2695986
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Phagocytosis and killing of Gardnerella vaginalis by human neutrophils.
    Easmon CS; Clark L; Crane JP; Green R
    J Clin Pathol; 1985 Jul; 38(7):747-9. PubMed ID: 3874884
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Deficient alternative complement pathway activity in newborn sera.
    Mills EL; Björksteń B; Quie PG
    Pediatr Res; 1979 Dec; 13(12):1341-4. PubMed ID: 392430
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Alternative pathway of complement in sickle cell disease.
    Strauss RG; Asbrock T; Forristal J; West CD
    Pediatr Res; 1977 Apr; 11(4):285-9. PubMed ID: 846782
    [TBL] [Abstract][Full Text] [Related]  

  • 17. An abnormality of the alternate pathway of complement activation in sickle-cell disease.
    Johnston RB; Newman SL; Struth AG
    N Engl J Med; 1973 Apr; 288(16):803-8. PubMed ID: 4144343
    [No Abstract]   [Full Text] [Related]  

  • 18. Deficiency of pneumococcal serum opsonizing activity in sickle-cell disease.
    Winkelstein JA; Drachman RH
    N Engl J Med; 1968 Aug; 279(9):459-66. PubMed ID: 4385710
    [No Abstract]   [Full Text] [Related]  

  • 19. The classical complement pathway plays a critical role in the opsonisation of uropathogenic Escherichia coli.
    Li K; Sacks SH; Sheerin NS
    Mol Immunol; 2008 Feb; 45(4):954-62. PubMed ID: 17870166
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Opsonization of Salmonella enteritidis lipopolysaccharide in sickle cell disease.
    Field RJ; Overturf GD; Strunk R
    Pediatr Res; 1981 Feb; 15(2):107-11. PubMed ID: 7019833
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.